{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:19:51Z","timestamp":1791206391794,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.03.018","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T08:53:18Z","timestamp":1238143998000},"page":"3063-3071","source":"Crossref","is-referenced-by-count":84,"title":["Intradermal immunization improves protective efficacy of a novel TB vaccine candidate"],"prefix":"10.1016","volume":"27","author":[{"given":"Susan L.","family":"Baldwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bertholet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Zharkikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Ireton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Vedvick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea N.","family":"Coler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.03.018_bib1","series-title":"Global tuberculosis control: surveillance, planning, financing: WHO report","author":"Dye","year":"2008"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.03.018_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.2006.03306.x","article-title":"Translational mini-review series on vaccines: development and evaluation of improved vaccines against tuberculosis","volume":"147","author":"Sander","year":"2007","journal-title":"Clinical and Experimental Immunology"},{"issue":"June (22)","key":"10.1016\/j.vaccine.2009.03.018_bib3","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","article-title":"Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally","volume":"293","author":"Dye","year":"2005","journal-title":"Journal of the American Medical Association"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.018_bib4","first-page":"656","article-title":"The success and failure of BCG\u2014implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nature Reviews"},{"issue":"11 (Dec)","key":"10.1016\/j.vaccine.2009.03.018_bib5","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis","volume":"181","author":"Bertholet","year":"2008","journal-title":"The Journal of Immunology"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.03.018_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.it.2004.06.005","article-title":"IL-4 in tuberculosis: implications for vaccine design","volume":"25","author":"Rook","year":"2004","journal-title":"Trends in Immunology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.03.018_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nature Reviews in Immunology"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2009.03.018_bib8","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.03.018_bib9","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"van Pinxteren","year":"2000","journal-title":"European Journal of Immunology"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.03.018_bib10","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"The Journal of Experimental Medicine"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.03.018_bib11","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"The Journal of Experimental Medicine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.03.018_bib12","first-page":"39","article-title":"Who puts the tubercle in tuberculosis?","volume":"5","author":"Russell","year":"2007","journal-title":"Nature Reviews"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2009.03.018_bib13","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin","volume":"162","author":"Bean","year":"1999","journal-title":"Journal of Immunology"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.03.018_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"issue":"October (15)","key":"10.1016\/j.vaccine.2009.03.018_bib15","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"December (15)","key":"10.1016\/j.vaccine.2009.03.018_bib16","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.micinf.2004.08.018","article-title":"Toll-like receptors: linking innate and adaptive immunity","volume":"6","author":"Pasare","year":"2004","journal-title":"Microbes and Infection\/Institut Pasteur"},{"issue":"December (6813)","key":"10.1016\/j.vaccine.2009.03.018_bib17","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2009.03.018_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4889(01)00182-3","article-title":"Toll-like receptors as adjuvant receptors","volume":"1589","author":"Kaisho","year":"2002","journal-title":"Biochimica et Biophysica Acta"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2009.03.018_bib19","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.163.7.3920","article-title":"Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis","volume":"163","author":"Means","year":"1999","journal-title":"Journal of Immunology"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2009.03.018_bib20","first-page":"279","article-title":"NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis","volume":"1","author":"Ferwerda","year":"2005","journal-title":"PLoS Pathogens"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.03.018_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nature Immunology"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2009.03.018_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4049\/jimmunol.174.2.742","article-title":"TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development","volume":"174","author":"Sun","year":"2005","journal-title":"Journal of Immunology"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.018_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells","volume":"6","author":"Napolitani","year":"2005","journal-title":"Nature Immunology"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.018_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.intimp.2007.04.006","article-title":"TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha","volume":"7","author":"Ghosh","year":"2007","journal-title":"International Immunopharmacology"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2009.03.018_bib25","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"Journal of Immunology"},{"issue":"14(July)","key":"10.1016\/j.vaccine.2009.03.018_bib26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/CDLI.00077-07","article-title":"A toll-like receptor-2 directed fusion protein vaccine against tuberculosis","author":"Wang","year":"2007","journal-title":"Clinical and Vaccine Immunology"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2009.03.018_bib27","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.176.12.7335","article-title":"Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes","volume":"176","author":"Zaks","year":"2006","journal-title":"Journal of Immunology"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.03.018_bib28","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2009.03.018_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annual Review of Immunology"},{"issue":"May (Suppl.)","key":"10.1016\/j.vaccine.2009.03.018_bib30","first-page":"126","article-title":"Antibody classes & subclasses induced by mucosal immunization of mice with Streptococcus pyogenes M6 protein & oligodeoxynucleotides containing CpG motifs","volume":"119","author":"Teloni","year":"2004","journal-title":"The Indian Journal of Medical Research"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.03.018_bib31","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/IAI.00846-07","article-title":"Agonists of toll-like receptors 3 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B","volume":"75","author":"Fransen","year":"2007","journal-title":"Infection and Immunity"},{"issue":"March (5663)","key":"10.1016\/j.vaccine.2009.03.018_bib32","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.03.018_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/eji.200323797","article-title":"Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines","volume":"33","author":"Edwards","year":"2003","journal-title":"European Journal of Immunology"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2009.03.018_bib34","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20020207","article-title":"Interferon-alpha and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets","volume":"195","author":"Ito","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.03.018_bib35","doi-asserted-by":"crossref","first-page":"13s","DOI":"10.1006\/clim.1999.4804","article-title":"The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans\u2019 cells","volume":"94","author":"Burns","year":"2000","journal-title":"Clinical Immunology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.03.018_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1523-1747.2000.00833.x","article-title":"Imiquimod, a topical immune response modifier, induces migration of Langerhans cells","volume":"114","author":"Suzuki","year":"2000","journal-title":"The Journal of Investigative Dermatology"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2009.03.018_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0738-081X(00)00173-5","article-title":"Immune functions of the skin","volume":"19","author":"Debenedictis","year":"2001","journal-title":"Clinics in Dermatology"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.03.018_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.smim.2005.05.009","article-title":"Cutaneous dendritic cells","volume":"17","author":"Valladeau","year":"2005","journal-title":"Seminars in Immunology"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2009.03.018_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cyto.2005.07.011","article-title":"Cytokines and Langerhans cell mobilisation in mouse and man","volume":"32","author":"Griffiths","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2009.03.018_bib40","article-title":"Characterisation of epidermal lipid composition and skin morphology of animal skin ex vivo","author":"Stahl","year":"2008","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"August\u2013September (3\u20134)","key":"10.1016\/j.vaccine.2009.03.018_bib41","first-page":"183","article-title":"Skin thickness of Korean adults","volume":"24","author":"Lee","year":"2002","journal-title":"Surgical and Radiologic Anatomy"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.018_bib42","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang","year":"2008","journal-title":"Infection and Immunity"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.03.018_bib43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/IAI.71.2.864-871.2003","article-title":"Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis","volume":"71","author":"Turner","year":"2003","journal-title":"Infection and Immunity"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.03.018_bib44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nature Medicine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T17:04:04Z","timestamp":1684947844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09004095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":44,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09004095"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}